SEATTLE--(BUSINESS WIRE)--Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, announced today that The Royal Marsden in London is the first cancer center in the United Kingdom to offer the Calypso® System to provide accurate, precise, real-time tumor tracking for patients undergoing external beam radiation therapy for prostate cancer.
